Dr. Reddy's Laboratories Ltd. (RDY) Stock News, Earnings & History

(NYSE:RDY) Healthcare

Enjoy Interactive Tools and Indicators

52wk high: 38.74
52wk low: 27.28
EPS: 1.86
P/E: 19.83
Div Rate: 0.23
Yield: 0.60
Market Cap: 6.26B
Avg Vol (3m): 243,779

Latest Headlines

More Articles About RDY →

Company On Twitter

Company Profile

Dr. Reddy's Laboratories Limited provides a complete range of pharmaceutical services. The Company manufactures bulk drugs and formulations including verapamil and cephalexin. The Company also manufactures and exports molecules such as norfloxacin, ciprofloxacin, and varieties of semi-synthetic penicillin. The Company markets its products in India and around the world.


Investor Relations | Press Releases

Insider Trading Cheat Sheet

No insider trading data available for Dr. Reddy's Laboratories Ltd..

Yahoo, HV, Market Watch, The Wall St. Journal